logo1-color.png
Groundbreaking Voice of the Patient Report for pediatric low-grade glioma (pLGG) published by Pediatric Brain Tumor Foundation
07 août 2024 09h30 HE | Pediatric Brain Tumor Foundation
Report documents the experiences of pLGG patients, survivors, their families, to inform future drug development for most common brain tumor type in kids
logo1-color.png
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
25 juin 2024 10h24 HE | Pediatric Brain Tumor Foundation
Ursula Burns, former Xerox CEO, and Jordan Wertlieb EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board
logo1-color.png
The Pediatric Brain Tumor Foundation Welcomes Dr. Sanjay Gupta to its Board of Directors
01 mai 2024 09h00 HE | Pediatric Brain Tumor Foundation
The Pediatric Brain Tumor Foundation Welcomes Dr. Sanjay Gupta to its Board of Directors
logo1-color.png
Pediatric Brain Tumor Foundation celebrates FDA approval of Day One Biopharmaceuticals’ OJEMDA™, new treatment for common pediatric brain tumor type
29 avr. 2024 15h30 HE | Pediatric Brain Tumor Foundation
Pediatric Brain Tumor Foundation celebrates FDA approval of Day One Biopharmaceuticals’ OJEMDA™, new treatment for common pediatric brain tumor type